Anonymous
Guest
Anonymous
Guest
It kills me that he thinks we lead and close for patients with T2DM alone and that he just now wants us to expand who we close for NMR usage. Get real. This is a joke. The reps in the field close for standard of care. NOT BY FOCUSSING ON PATIENTS WITH T2DM. Does he really think he’s teaching us something new by asking us to expand. We’ve been doing that!!! The reps who are doing well, making their #’s and have been selling this test for years know how to close for usage. Stop telling us how to message based on T2DM. Go back to pharma. If I lead with patients with diabetes I would corner myself majority of the time and my numbers would go down. AND...enough with IMS targeting. You don’t sell a lab test based on pharma IMS data.